Back to XTX Topco Ltd XTX Topco Ltd

CURXCURX
3 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in CURANEX PHARMACEUTICALS INC

No. XTX Topco exited its CURX (Curanex Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 51,289 shares worth $26,224. XTX Topco first reported CURX in Q4 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$14,012

Total Shares Change

-42,385

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.27
0
2026-Q1
Increased
51,289
+21.0%
$26,2240.0%$0.46
23
2025-Q4
New
42,385
-
$14,0120.0%$0.34
25

Other major holders of CURX: GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used